Top Markets
#1 Prom Prom +31.82%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +26.81%
#4 UnifAI Network UnifAI Network +23.28%
#5 Tutorial Tutorial +22.65%
#6 Pons Pons +22.39%
#7 Wrapped STX (Velar) Wrapped STX (Velar) +18.10%
#8 Versatize Coin Versatize Coin +16.66%
#9 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +16.63%
#10 Derive Derive +15.85%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Tien Liang BioTech Co., Ltd. Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd.

4127
Rank in Stocks #20704
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New... Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
Share Price
$2.71
Market Cap
$124.12M
Change (1 day)
-3.62%
Change (1 year)
138.18%
Country
TW
Trade Tien Liang BioTech Co., Ltd. (4127)

Category

Healthcare
Revenue for Tien Liang BioTech Co., Ltd. (4127)
Revenue in Aug 2026 TTM: 0
According to Tien Liang BioTech Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Tien Liang BioTech Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN